Cite
HARVARD Citation
Hussain, S. et al. (2022). Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. Lancet oncology. 23 (5), pp. 650-658. [Online].